Muscle Pharm Corporation (MSLPQ)

[turokman]

9 Month revenue is 74-76 million, market cap is 5 million. This is trading at 1/20th of annual sales.

The Company plans to restate its unaudited condensed consolidated financial statements for the Restated Periods by filing an amended Form 10-Q for the period ended September 30, 2018 (the “Amended Form 10-Q”). It was determined that similar errors existed in the quarter ended June 30, 2018, but the impact was not deemed material to that period. We expect that certain amounts in the condensed consolidated financial statements for the Restated Periods, which will be included in the Amended Form 10-Q, will differ from the amounts reported in the original filing. Revenue, net, as restated, for the nine-month period ended September 30, 2018 is expected to be in a range of approximately $74 million to $76 million.

https://www.sec.gov/Archives/edgar/data/1415684/000165495419002745/mslp_8k.htm

$MSLP